Thierry Bordet

Company: PulseSight Therapeutics

Job title: Chief Scientific & Operating Officer

Seminars:

A Novel Approach to Protect Photoreceptors and RPE Integrity to Slow Geographic Atrophy Progression 4:30 pm

Exploring the emerging role of ferroptosis — an iron-dependent, lipid peroxidation-driven form of programmed cell death — in retinal pigment epithelium (RPE) and photoreceptor degeneration in dry AMD Highlighting the therapeutic potential of transferrin, the primary iron-transport protein, to restore iron homeostasis and mitigate oxidative stress, dysregulated lipid metabolism, inflammation, complement activation, and ferroptosis Presenting…Read more

day: Day1